Back to top of page

NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)

1. Name of the small business applying for the grant

2. Contact information for the small business (including address, phone number, and email)

3. Description of the investigational agent being studied (drug, biologic, surgical therapy, or device)

4. Explanation of how the investigational agent may contribute to the justification for designing clinical studies

5. List of diseases chosen for study and justification for their selection based on the NINDS strategic plan and clinical research interests

6. Research plan for the exploratory clinical trial, including objectives, methodology, and anticipated outcomes

7. Budget for the proposed trial, including details on how the grant funds will be used

8. Timeline for the trial, including expected start and end dates

9. Qualifications and experience of the project team members, including the principal investigator and any collaborating researchers

10. Consent and ethics considerations for the trial, including plans for obtaining informed consent from participants and ensuring patient safety and privacy

11. Any additional supporting documents or references that may be required for the application.

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows